Pacer Advisors, Inc. Revolution Medicines, Inc. Transaction History
Pacer Advisors, Inc.
- $39 Billion
- Q2 2024
A detailed history of Pacer Advisors, Inc. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 1,056 shares of RVMD stock, worth $46,643. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,056
Previous 1,326
20.36%
Holding current value
$46,643
Previous $42,000
4.76%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding RVMD
# of Institutions
231Shares Held
161MCall Options Held
251KPut Options Held
133K-
Vanguard Group Inc Valley Forge, PA14.4MShares$635 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA13.7MShares$603 Million0.1% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$592 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA9.76MShares$431 Million1.83% of portfolio
-
Baker Bros. Advisors LP New York, NY7.57MShares$334 Million3.9% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.87B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...